CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 55 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $259,532 | +30.8% | 169,629 | 0.0% | 0.01% | +20.0% |
| Q4 2023 | $198,466 | +34.5% | 169,629 | 0.0% | 0.01% | -90.7% |
| Q3 2023 | $147,560 | -22.3% | 169,629 | 0.0% | 0.05% | -8.5% |
| Q2 2023 | $189,984 | +7.7% | 169,629 | 0.0% | 0.06% | +3.5% |
| Q1 2023 | $176,414 | +92749.5% | 169,629 | 0.0% | 0.06% | +3.6% |
| Q4 2022 | $190 | – | 169,629 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,750,107 | $10,875,000 | 0.41% |
| Plante Moran Financial Advisors, LLC | 50,000 | $145,000 | 0.05% |
| Donald L. Hagan, LLC | 14,000 | $40,000 | 0.04% |
| Game Plan Financial Advisors, LLC | 11,000 | $32,000 | 0.03% |
| Tekla Capital Management LLC | 165,330 | $479,000 | 0.02% |
| Virtu Financial LLC | 52,655 | $153,000 | 0.02% |
| SIGNATUREFD, LLC | 58,326 | $169,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 131,783 | $382,000 | 0.01% |
| Lindbrook Capital, LLC | 10,000 | $29,000 | 0.01% |
| WEDBUSH SECURITIES INC | 40,700 | $118,000 | 0.01% |